<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02212834</url>
  </required_header>
  <id_info>
    <org_study_id>CE-1304-6656</org_study_id>
    <nct_id>NCT02212834</nct_id>
  </id_info>
  <brief_title>Surveillance Imaging Modalities for Breast Cancer Assessment</brief_title>
  <acronym>SIMBA</acronym>
  <official_title>Comparative Effectiveness of Surveillance Modalities in Breast Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harvard Pilgrim Health Care</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Patient-Centered Outcomes Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effectiveness of surveillance breast MRI
      compared to mammography alone in women with a personal history of breast cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our overall aim is to find out how well MRI works compared with mammography for surveillance
      in women who have previously had breast cancer. Specifically, our goals are to:

        1. Understand doctors' and patients' experiences with surveillance mammography and MRI

        2. Provide evidence on which outcomes are more or less likely to occur

        3. Develop patient decision aids to help women and their doctors choose the surveillance
           method that is right for them

      How we will conduct the study: We will work with patients, doctors, policy makers, advocacy
      groups, and researchers to improve surveillance for women who have a personal history of
      breast cancer. Through focus groups with patients and interviews with doctors, we will gain
      insights into women's experience with surveillance mammography and MRI. We will also compare
      mammography to MRI using data from the Breast Cancer Surveillance Consortiumâ€”the largest
      collection of breast cancer surveillance data in the nation. We will use data from more than
      13,000 women diagnosed with breast cancer between 2005 and 2012 to determine how well each
      test works. We will measure the tests' effectiveness at finding second cancers, and estimate
      the likelihood of different outcomes. We will also determine whether one test appears to work
      better than the other to detect second breast cancers among different groups of women. We
      will then develop patient decision aids to help women and their doctors make more-informed
      choices about surveillance.

      What we hope to achieve: We hope this study will improve medical decision making and care for
      the 3 million women in the United States who have a history of breast cancer. Specifically,
      our results will help women and their doctors make clearer, better choices about the
      surveillance method that is right for them.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Breast Cancers Detected</measure>
    <time_frame>12 months post surveillance exam</time_frame>
    <description>Number of second breast cancers detected in the 12 months after surveillance mammogram or breast MRI</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">36444</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Mammograms</arm_group_label>
    <description>Surveillance mammograms in women with a personal history of breast cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast MRI</arm_group_label>
    <description>Surveillance breast Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Surveillance imaging exams in women included in the Breast Cancer Surveillance Consortium
        who are 18+ years of age at the the of a Stage 0-III incident breast cancer diagnosis
        between January 1, 2005 and December 31, 2012.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: Surveillance imaging exams in women included in the Breast Cancer
        Surveillance Consortium who are 18+ years of age at the the of a Stage 0-III incident
        breast cancer diagnosis between January 1, 2005 and December 31, 2012.

        Exclusion Criteria:

          -  Women with a diagnosis of lobular carcinoma in situ

          -  Women with missing cancer staging data from Surveillance, Epidemiology and End Results
             (SEER) Program records

          -  Women with Stage 4 breast cancer at time of diagnosis

          -  Women with a diagnosis of a second breast cancer event within six months of the
             primary diagnosis

          -  Women who die within six months of primary diagnosis

          -  Women who have had a double mastectomy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen J. Wernli, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Group Health Research Institute</affiliation>
  </overall_official>
  <link>
    <url>https://www.artefactgroup.com/work/simba-breast-cancer-decisions-aid/</url>
    <description>SIMBA Decision tool</description>
  </link>
  <link>
    <url>https://vimeo.com/154765251</url>
    <description>Video of impact of patient engagement in research</description>
  </link>
  <link>
    <url>https://breastscreening.cancer.gov/</url>
    <description>Homepage for the Breast Cancer Surveillance Consortium</description>
  </link>
  <reference>
    <citation>Johnson DS, Bush MT, Brandzel S, Wernli KJ. The patient voice in research-evolution of a role. Res Involv Engagem. 2016 Feb 22;2:6. doi: 10.1186/s40900-016-0020-4. eCollection 2016.</citation>
    <PMID>29062507</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2014</study_first_submitted>
  <study_first_submitted_qc>August 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2014</study_first_posted>
  <results_first_submitted>November 28, 2016</results_first_submitted>
  <results_first_submitted_qc>December 13, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 7, 2017</results_first_posted>
  <last_update_submitted>October 11, 2017</last_update_submitted>
  <last_update_submitted_qc>October 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast</keyword>
  <keyword>Cancer</keyword>
  <keyword>Surveillance</keyword>
  <keyword>Imaging</keyword>
  <keyword>Comparative</keyword>
  <keyword>Effectiveness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Cohort analysis of women with one or more observed breast cancer surveillance exams and primary cancer diagnosis between 2003 and 2012</recruitment_details>
      <pre_assignment_details>Not a clinical trial. Analyses were conducted with the entire population who met study criteria. Unit of analysis was surveillance exam.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Mammograms</title>
          <description>Surveillance mammograms in women with a personal history of breast cancer</description>
        </group>
        <group group_id="P2">
          <title>Breast MRI</title>
          <description>Surveillance Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33938"/>
                <participants group_id="P2" count="2506"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33938"/>
                <participants group_id="P2" count="2506"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Characteristics at time of surveillance exam</population>
      <group_list>
        <group group_id="B1">
          <title>Mammograms</title>
          <description>Surveillance mammograms in women with a personal history of breast cancer</description>
        </group>
        <group group_id="B2">
          <title>Breast MRI</title>
          <description>Surveillance breast Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33,938"/>
            <count group_id="B2" value="2,506"/>
            <count group_id="B3" value="36444"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>surveillance exams</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33938"/>
            <count group_id="B2" value="2506"/>
            <count group_id="B3" value="36444"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>surveillance exams</units>
          <param>Count of Units</param>
          <units_analyzed>surveillance exams</units_analyzed>
          <class_list>
            <class>
              <title>Age at exam</title>
              <category_list>
                <category>
                  <title>18 - 39 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="388"/>
                    <measurement group_id="B2" value="153"/>
                    <measurement group_id="B3" value="541"/>
                  </measurement_list>
                </category>
                <category>
                  <title>40 - 49 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3,635"/>
                    <measurement group_id="B2" value="574"/>
                    <measurement group_id="B3" value="4209"/>
                  </measurement_list>
                </category>
                <category>
                  <title>50 - 59 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8,626"/>
                    <measurement group_id="B2" value="1,005"/>
                    <measurement group_id="B3" value="9631"/>
                  </measurement_list>
                </category>
                <category>
                  <title>60 - 69 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9,852"/>
                    <measurement group_id="B2" value="632"/>
                    <measurement group_id="B3" value="10484"/>
                  </measurement_list>
                </category>
                <category>
                  <title>70 - 79 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7,167"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="7300"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt; or = 80 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4,270"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="4279"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>surveillance exams</units>
          <param>Count of Units</param>
          <units_analyzed>surveillance exams</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33,938"/>
                    <measurement group_id="B2" value="2,506"/>
                    <measurement group_id="B3" value="36444"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>surveillance exams</units>
          <param>Count of Units</param>
          <units_analyzed>surveillance exams</units_analyzed>
          <class_list>
            <class>
              <title>Race/ethnicity at time of exam</title>
              <category_list>
                <category>
                  <title>White, non-hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26,717"/>
                    <measurement group_id="B2" value="2,069"/>
                    <measurement group_id="B3" value="28786"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black, non-hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2,862"/>
                    <measurement group_id="B2" value="62"/>
                    <measurement group_id="B3" value="2924"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1,042"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="1109"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian or Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2,583"/>
                    <measurement group_id="B2" value="219"/>
                    <measurement group_id="B3" value="2802"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mixed or Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="657"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="745"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Missing</title>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Breast Cancers Detected</title>
        <description>Number of second breast cancers detected in the 12 months after surveillance mammogram or breast MRI</description>
        <time_frame>12 months post surveillance exam</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mammograms</title>
            <description>Surveillance mammograms in women with a personal history of breast cancer</description>
          </group>
          <group group_id="O2">
            <title>Breast MRI</title>
            <description>Surveillance breast Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Breast Cancers Detected</title>
          <description>Number of second breast cancers detected in the 12 months after surveillance mammogram or breast MRI</description>
          <units>cancers detected</units>
          <param>Number</param>
          <units_analyzed>exams</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33,938"/>
                <count group_id="O2" value="2,506"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>exams</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33938"/>
                <count group_id="O2" value="2506"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="279"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>This study was not a clinical trial. It was a cohort analysis, with no study intervention and no participant contact. Adverse events are not applicable.</desc>
      <group_list>
        <group group_id="E1">
          <title>Mammograms</title>
          <description>Surveillance mammograms in women with a personal history of breast cancer</description>
        </group>
        <group group_id="E2">
          <title>Breast MRI</title>
          <description>Surveillance breast Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This study was not a clinical trial. It was a cohort analysis of existing data.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Karen J. Wernli, PhD</name_or_title>
      <organization>Group Health Research Institute</organization>
      <phone>206-287-2934</phone>
      <email>wernli.k@ghc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

